Logo
Int J Infect

Image Credit:Int J Infect

Prevalence of Bacterial Nosocomial Infections in the ICU Ward of Shohada-Ashayer Hospital of Khorramabad, 2018

Author(s):
Pegah ShakibPegah Shakib1, Sina BakhtiarSina Bakhtiar2, Tabassom ZavariTabassom ZavariTabassom Zavari ORCID3, Khatereh AnbariKhatereh AnbariKhatereh Anbari ORCID4, Shahnaz HalimiShahnaz Halimi5, Faranak RezaeiFaranak RezaeiFaranak Rezaei ORCID6,*
1Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
2School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
3Department of Infectious and Tropical Diseases Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
4Social Determinants of Health Research Center, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
5Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6Department of Microbiology, Razi Herbal Medicines Research Center, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran


International Journal of Infection:Vol. 11, issue 1; e151830
Published online:Jan 30, 2024
Article type:Research Article
Received:Oct 30, 2023
Accepted:Jan 20, 2024
How to Cite:Pegah ShakibSina BakhtiarTabassom ZavariKhatereh AnbariShahnaz HalimiFaranak Rezaeiet al.Prevalence of Bacterial Nosocomial Infections in the ICU Ward of Shohada-Ashayer Hospital of Khorramabad, 2018.Int J Infect.11(1):e151830.https://doi.org/10.5812/iji-151830.

Abstract

Background:

Hospital infections are among the most significant health problems, affecting the quality of health services in hospitals and leading to increased hospitalization costs, prolonged treatment durations, the spread of various infections in society, and even mortality among hospitalized patients. In recent years, these infections have increased worldwide.

Objectives:

The present study investigated the epidemiological aspects of nosocomial infections in the intensive care unit (ICU) of Shohada-Ashayer Hospital in Khorramabad during the first nine months of 2018.

Methods:

In this cross-sectional study, conducted from April 2018 to December 2018, all patients hospitalized in the ICU of Shohada-Ashayer Hospital, Khorramabad, were evaluated for nosocomial infections.

Results:

This study found that out of 917 patients hospitalized in the ICU, 92 patients (10%) contracted nosocomial infections. Among these, 59 (64.1%) were men and 33 (35.9%) were women, with an average age of 61.23 ± 18.64 years. The youngest patient was 18 years old, and the oldest was 95 years old. The highest prevalence of nosocomial infection was catheter-associated infections, accounting for 37 cases (40.3%), followed by urinary tract infections (UTI) with 31 cases (33.7%). The highest antibiotic resistance was observed against cotrimoxazole (74 cases, 80.4%), ceftriaxone (67 cases, 72.8%), and ceftazidime (67 cases, 72.8%), while the highest antibiotic susceptibility was to ciprofloxacin (24 cases, 26.1%) and amikacin (22 cases, 23.9%). The most frequently isolated bacterium from the cultures of the studied patients was Acinetobacter spp., found in 26 cases (28.3%).

Conclusions:

These results indicate that nosocomial infections in the ICU, particularly those associated with the use of invasive devices such as catheters, are a major cause of hospital-acquired infections. Additionally, the high level of drug resistance observed in various isolated microorganisms is a serious concern.

1. Background

The US Department of Health estimates that nosocomial infections result in an annual financial burden of $5 - 10 billion in healthcare expenses and cause 99,000 deaths. They are also a common cause of more serious consequences, increased mortality, and longer hospital stays (1, 2). The frequency of nosocomial infections, ranging from 5% to 15%, directly correlates with hospital quality. Treatment for nosocomial infections is expensive; however, over half of these infections can be managed, and their spread stopped, for significantly less money (3).

Nosocomial infections are one of the most frequent medical issues that hospitalized patients in intensive care units (ICUs) experience (4, 5). They affect 5% to 15% of patients in high-income countries, with 37% to 49% of these infections occurring in critical care units. Patients in ICUs often have immunosuppressive conditions, increasing their susceptibility to nosocomial infections (6). Hospitals in Southeast Asia (10%), the Eastern Mediterranean (11.8%), Europe (7.7%), and the Western Pacific (9%) report the highest rates of nosocomial infections. Research from the World Health Organization (WHO) indicates that orthopedic and surgical units, as well as ICUs, have the highest incidence of nosocomial infections (7). More than 20% of nosocomial infection cases occur in the ICU department, with a raw mortality rate due to nosocomial infection in this department ranging from 10% to 80%. The most common causes of pneumonia are mechanical ventilation, intra-abdominal infections, and bacteremia secondary to intravenous injections, depending on vascularity (8, 9). This problem has been exacerbated by the development of transmissible resistance in pathogens to antibiotics (10). These infections occasionally result in patient deaths and pose a risk to those admitted to hospitals (11).

To assess the effectiveness of current infection prevention initiatives and develop future hospital and national intervention plans, accurate data on the prevalence of these infections are required. Consequently, identifying the origin and contributing factors of nosocomial infections and implementing suitable infection control strategies may reduce the risk of infection and the associated mortality in affected individuals (12).

2. Objectives

This study aimed to ascertain the incidence of nosocomial infections during the first nine months of 2018 in the ICU of Shohada-Ashayer Hospital in Khorramabad.

3. Methods

The current cross-sectional study was conducted at the special care unit of Shohada-Ashayer Hospital in Khorramabad, Iran, over a nine-month period, from April 1 to December 31, 2018.

3.1. Study Type and Entry and Exit Criteria

All patients admitted to the special care unit of Shohada-Ashayer Hospital in 2018 who exhibited symptoms of nosocomial infections (such as high fever, elevated heart rate, leukocytosis, and sputum) after a minimum of 72 hours of hospital stay were included based on the inclusion criteria. They underwent cultures in addition to radiological assessments, coughing, and other indications of possible nosocomial infection. The researchers adhered to ethical guidelines by maintaining the confidentiality of patient information throughout the research process.

3.2. Sample Collection

In this study, samples from all hospitalized patients suspected of having nosocomial infections based on clinical symptoms were collected on various culture media, including blood agar, chocolate agar, and eosin methylene blue. After incubation, the culture results were examined and identified using standard microbial tests such as gram staining, catalase, coagulase, citrate, indole, triple sugar iron (TSI), methyl red Voges-Proskauer (MR-VP), DNase, urea, and oxidation-fermentation (OF) tests (13). We then evaluated these results to determine the presence of nosocomial infections. Nosocomial infections are defined as infections that develop during hospitalization, where the infectious agent is acquired from the hospital environment. These infections do not exist in the patient upon admission and develop within 48 to 72 hours after hospitalization (14).

3.3. Determination of Microbial Susceptibility

The pattern of antibiotic resistance was determined using the disc diffusion method according to CLSI guidelines, employing antibiotic discs. The antibiotics tested included ciprofloxacin, ofloxacin, imipenem, clindamycin, cefoxitin, amikacin, cefixime, piperacillin, ceftazidime, ceftriaxone, meropenem, gentamicin, cotrimoxazole, azithromycin, rifampin, ampicillin, vancomycin, nitrofurantoin, cefepime, and cefazolin (Padtan Teb Co., Iran). These tests were performed on Mueller Hinton Agar (Merck, Germany) (15).

3.4. Data Analysis

SPSS version 22 was used to analyze the data. Depending on the type of variable, frequency, mean, and standard deviation calculations were utilized to establish the study's descriptive objectives.

4. Results

Out of 917 patients hospitalized in the special care units of Shohada-Ashayer Hospital, 92 patients suffered from nosocomial infections, resulting in a prevalence of 10%. These 92 patients hospitalized in the ICUs and special care units were examined for the frequency of nosocomial infections. The mean age of the studied patients was 61.23 ± 18.64 years, with the youngest patient being 18 years old and the oldest 95 years old. Among all the patients, 59 (64.1%) were male and 33 (35.9%) were female. The information of the studied patients is shown in Table 1. The highest rate of nosocomial infections was related to catheter infections (with positive clinical symptoms, positive blood culture, and positive catheter culture) at 40.3%, followed by urinary tract infections (UTI) at 33.7%.

Table 1.Demographic Information of the Studied Patients
VariablesNo. (%)
Age
< 65 48 (52.2)
> 6544 (47.8)
Gender
Female33 (35.9)
Man59 (64.1)
History of infection
Diabetes30 (32.6)
High blood pressure64 (69.6)
Cardiovascular diseases41 (44.6)
Cancer1 (1.1)
Chronic kidney disease3 (3.3)
The type of underlying disease leading to hospitalization of patients
Stroke33 (35.9)
Multiple traumas26 (28.3)
Cardiovascular events5 (5.4)
Intracerebral hemorrhage17 (18.5)
Type of nosocomial infection
Catheter 37 (40.3)
Blood16 (17.4)
Urinary31 (33.7)
Respiratory8 (8.7)
Offensive devices
Foley tube89 (96.7)
Stomach tube83 (90.2)
Central venous catheter15 (16.3)
Sheldon4 (4.3)
Sheldon tracheostomy32 (34.8)
Intubation83 (90.2)
Chest tube12 (13)

Demographic Information of the Studied Patients

The results of the examination of antibiotic sensitivity and resistance patterns are shown in Table 2. The highest rates of resistance were observed for cotrimoxazole (80.4%), ceftriaxone (72.8%), and ceftazidime (72.8%), while the highest rates of sensitivity were observed for ciprofloxacin (26.1%) and amikacin (23.9%). The most frequently isolated bacteria from the cultures of the studied patients were Acinetobacter spp. (28.3%), Pseudomonas aeruginosa (17.4%), and Klebsiellapneumoniae (17.4%). The lowest frequency was related to Enterococcus spp. (1.1%) and Staphylococcusaureus (2.2%) isolated from the cultures of the patients (Table 3).

Table 2.The Pattern of Antibiotic Sensitivity and Resistance in the Studied Patients a
Antibiotics ResistanceSensitiveIntermediateNot Checked
Ciprofloxacin63 (68.5)24 (26.1)4 (4.3)1 (1.1)
Ofloxacin13 (14.1)9 (9.8)1 (1.1)69 (75 )
Clindamycin13 (14.1)1 (1.1)-78 (84.8)
Gentamicin54 (58.7)21 (22.8)5 (5.4)12 (13 )
Cefazolin70 (76.1)7 (7.6)1 (1.1)14 (15.2)
Cefepime48 (52.2)19 (20.7)3 (3.3)22 (23.9)
Meropenem50 (54.3)19 (20.7)1 (1.1)22 (23.9)
Piperacillin9 (9.8)4 (4.3)1 (1.1)78 (84.8)
Amikacin41 (44.6)22 (23.9)7 (7.6)22 (23.9)
Ceftriaxone67 (72.8)5 (5.4)1 (1.1)19 (20.7)
Ceftazidime 67 (72.8)10 (10.9)2 (2.2)13 (14.1)
Cefoxitin5 (5.4)7 (7.6)-80 (87 )
Cefixime14 (15.2)4 (4.3)-74 (80.4)
Imipenem50 (54.3)20 (21.7)3 (3.3)19 (20.7)
Nitrofurantoin6 (6.5)7 (7.6)1 (1.1)78 (84.8)
Vancomycin7 (7.6)13 (14.1)-72 (78.3)
Ampicillin57 (62 )5 (5.4)3 (3.3)20 (21.7)
Rifampin8 (8.7)5 (5.4)1 (1.1)78 (84.8)
Azithromycin 5 (5.4)1 (1.1)-86 (93.5)
Cotrimoxazole74 (80.4)8 (8.7)1 (1.1)9 (9.8)

The Pattern of Antibiotic Sensitivity and Resistance in the Studied Patients a

Table 3.The Abundance of Bacteria Isolated from the Cultures of the Studied Patients
Bacteria No. (%)
Escherichia coli12 (13)
Staphylococcus epidermidis10 (10.9)
Pseudomonas aeruginosa16 (17.4)
Acinetobacter26 (28.3)
Klebsiella pneumoniae16 (17.4)
Enterococcus1 (1.1)
Streptococcus5 (5.4)
Corynebacterium4 (4.3)
Staphylococcus aureus 2 (2.2)
Total92 (100)

The Abundance of Bacteria Isolated from the Cultures of the Studied Patients

Based on the results from Figures 1 and 2 of the chi-square tests, the differences in the frequency of nosocomial infections by age (P = 0.419) and gender (P = 0.473) were not statistically significant. The differences in the frequency of nosocomial infections by history of diabetes (P = 0.828) and history of hypertension (P = 0.296) were also not significant, but there was a significant difference by history of cardiovascular diseases (P = 0.013). The most frequently isolated bacteria from patient cultures were Acinetobacterbaumannii (28.3%), P. aeruginosa (17.4%), and K.pneumoniae (17.4%). The least frequently isolated bacteria were Enterococcus spp. (1.1%) and S.aureus (2.2%). The frequency distribution of nosocomial infections was significantly different according to the type of bacteria (P = 0.001). The frequency of nosocomial infections in patients was not significantly different according to the type of inpatient department (P = 0.28). In the general ICU, the highest rate of nosocomial infections was catheter infection. In the surgical ICU, the highest frequency was related to urinary infection, and in the burn ICU, the highest frequency was related to blood infection. In the CCU, the frequency of catheter, blood, and urinary infections was 33.3% each, but these differences were not significant. The difference in the frequency of nosocomial infections in patients according to the type of antibiotic received in the first 24 hours was not significant (P = 0.666). The difference in the frequency of nosocomial infections in patients by the type of underlying disease leading to hospitalization in the ICU was not significant (P = 0.140). The difference in the frequency of patient outcomes by the types of nosocomial infections was not significant (P = 0.934), indicating no statistically significant relationship between patient outcome and the type of nosocomial infections. The difference in the distribution of the frequency of patient outcomes by the status of response to antibiotics in the first 24 hours was not significant (P = 0.211). The difference in the distribution of the frequency of nosocomial infections in patients according to the status of response to antibiotics prescribed in the first 24 hours was not significant (P = 0.774).

Frequency distribution of types of nosocomial infections in the studied patients by gender
Figure 1.

Frequency distribution of types of nosocomial infections in the studied patients by gender

Frequency distribution of nosocomial infections in the studied patients by age
Figure 2.

Frequency distribution of nosocomial infections in the studied patients by age

5. Discussion

The prevalence of nosocomial infections is closely related to the level of hospital hygiene; in hospitals with advanced health systems, this rate is less than 5%. Due to the severity of the disease, the length of hospitalization, and the use of invasive methods, the ICU is one of the high-risk areas for nosocomial infections (16-19)). In this study, the prevalence of nosocomial infections was 10%, consistent with the findings of Amini (20). In contrast, the study by HajiBagheri and Afrasiabian reported a prevalence rate of 15.6% (21). This difference could be due to the variation in the number of examined beds in the care units. According to international standards, the acceptable level of nosocomial infections for developed countries ranges from 5% to 20%, and the prevalence observed in this study aligns with these standards (12, 22-24).

Regarding the type of nosocomial infections, the highest frequency was related to catheter-associated infections at 40.3%, followed by urinary infections at 33.7%. The results of this study and those by Fereidooni Moghadam et al. showed that the most common nosocomial infections in special care departments were related to arterial and venous catheters (88%), which is consistent (25). The study indicated that the highest frequency of bacteria isolated from patient cultures was A.baumannii (28.3%), P. aeruginosa (17.4%), and K.pneumoniae (17.4%). This finding is consistent with Yaghubi et al.'s study (26) and Amini (20), but not with K. pneumoniae, E. coli, and Enterobacter spp. in HajiBagheri and Afrasiabian's study, possibly due to a higher rate of intubation in their patients (21).

The study showed the highest resistance rates to cotrimoxazole (80.4%), ceftriaxone (72.8%), and ceftazidime (72.8%), while the highest sensitivity was to ciprofloxacin (26.1%) and amikacin (23.9%). These results align with Bahrami et al.'s study (27) but differ from Yaghubi et al.'s study (26), likely due to variations in the organisms isolated and their prevalence in hospital environments. The relationship between the prevalence of nosocomial infections and age, sex, and history of previous diseases was significant. In the surgical ICU, the highest frequency of nosocomial infections was related to UTI, consistent with Hussainrezaee et al.'s study (28). In the burn ICU, the highest frequency was related to blood infections, consistent with Askaryan et al.'s study (29). In the CCU, the frequency of catheter, blood, and urinary infections was 33.3% each; however, this study found no statistically significant difference between the types of infections, hospitals, and the type of inpatient ICU (P < 0.05).

5.1. Conclusions

According to the results, it can be concluded that the prevention of nosocomial infections requires precise and well-planned activities and programs. These can include the correct and timely use of medical interventions to limit the transmission of microorganisms, such as handwashing, especially by healthcare workers, infection monitoring and diagnosis, epidemic control, health education, continuous monitoring at the hospital level, proper use of disposable devices, controlled use of antibiotics, and careful wound care.

Footnotes

References

  • 1.
    Edwardson S, Cairns C. Nosocomial infections in the ICU. Anaesth Intens Care Med. 2019;20(1):14-8. https://doi.org/10.1016/j.mpaic.2018.11.004.
  • 2.
    Li Y, Ren L, Zou J. Risk Factors and Prevention Strategies of Nosocomial Infection in Geriatric Patients. Canadian J Infect Dis Med Microbiol. 2019;2019:1-5. https://doi.org/10.1155/2019/6417959.
  • 3.
    Wang L, Zhou KH, Chen W, Yu Y, Feng SF. Epidemiology and risk factors for nosocomial infection in the respiratory intensive care unit of a teaching hospital in China: A prospective surveillance during 2013 and 2015. BMC Infect Dis. 2019;19(1):145. [PubMed ID: 30755175]. [PubMed Central ID: PMC6373110]. https://doi.org/10.1186/s12879-019-3772-2.
  • 4.
    Zaragoza R, Vidal-Cortes P, Aguilar G, Borges M, Diaz E, Ferrer R, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020;24(1):383. [PubMed ID: 32600375]. [PubMed Central ID: PMC7322703]. https://doi.org/10.1186/s13054-020-03091-2.
  • 5.
    Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control. 2020;48(4):423-32. https://doi.org/10.1016/j.ajic.2019.08.023.
  • 6.
    Klevens R, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Pub Health Rep. 2007;122(2):160-6. https://doi.org/10.1177/003335490712200205.
  • 7.
    Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis. 2004;10(4):561-6. [PubMed ID: 15200842]. [PubMed Central ID: PMC3086182]. https://doi.org/10.3201/eid1004.020754.
  • 8.
    Nouri F, Karami P, Zarei O, Kosari F, Alikhani MY, Zandkarimi E, et al. Prevalence of Common Nosocomial Infections and Evaluation of Antibiotic Resistance Patterns in Patients with Secondary Infections in Hamadan, Iran. Infect Drug Resist. 2020;13:2365-74. [PubMed ID: 32765011]. [PubMed Central ID: PMC7369413]. https://doi.org/10.2147/IDR.S259252.
  • 9.
    Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020. Emerg Infect Dis. 2020;26(11):2694-6. [PubMed ID: 32852265]. [PubMed Central ID: PMC7588547]. https://doi.org/10.3201/eid2611.203504.
  • 10.
    Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect. 2005;60(1):40-5. [PubMed ID: 15823655]. https://doi.org/10.1016/j.jhin.2004.09.038.
  • 11.
    Zolldann D, Haefner H, Poetter C, Buzello S, Sohr D, Luetticken R, et al. Assessment of a selective surveillance method for detecting nosocomial infections in patients in the intensive care department. Am J Infect Control. 2003;31(5):261-5. [PubMed ID: 12888760]. https://doi.org/10.1067/mic.2003.72.
  • 12.
    Sikora A, Zahra F. Nosocomial Infections. In: Sikora A, Zahra F, editors. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
  • 13.
    Forbes BA, Sahm DF, Weissfeld AS. Diagnostic microbiology. USA: Mosby St Louis; 2007.
  • 14.
    Bereket W, Hemalatha K, Getenet B, Wondwossen T, Solomon A, Zeynudin A, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012;16(8):1039-44. [PubMed ID: 22913154].
  • 15.
    Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, et al. CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. J Clin Microbiol. 2018;56(4). [PubMed ID: 29367292]. [PubMed Central ID: PMC5869819]. https://doi.org/10.1128/JCM.01934-17.
  • 16.
    Lu D, Wang H, Yu R, Yang H, Zhao Y. Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers. J Hosp Infect. 2020;104(4):454-5. [PubMed ID: 32114056]. [PubMed Central ID: PMC7124261]. https://doi.org/10.1016/j.jhin.2020.02.018.
  • 17.
    Kramer TS, Schroder C, Behnke M, Aghdassi SJ, Geffers C, Gastmeier P, et al. Decrease of methicillin resistance in Staphylococcus aureus in nosocomial infections in Germany-a prospective analysis over 10 years. J Infect. 2019;78(3):215-9. [PubMed ID: 30658080]. https://doi.org/10.1016/j.jinf.2018.12.005.
  • 18.
    Akamatsu R, Suzuki M, Okinaka K, Sasahara T, Yamane K, Suzuki S, et al. Novel Sequence Type in Bacillus cereus Strains Associated with Nosocomial Infections and Bacteremia, Japan. Emerg Infect Dis. 2019;25(5):883-90. [PubMed ID: 31002057]. [PubMed Central ID: PMC6478208]. https://doi.org/10.3201/eid2505.171890.
  • 19.
    Lo MY, Ngan WY, Tsun SM, Hsing HL, Lau KT, Hung HP, et al. A Field Study Into Hong Kong's Wet Markets: Raised Questions Into the Hygienic Maintenance of Meat Contact Surfaces and the Dissemination of Microorganisms Associated With Nosocomial Infections. Front Microbiol. 2019;10:2618. [PubMed ID: 31781084]. [PubMed Central ID: PMC6861454]. https://doi.org/10.3389/fmicb.2019.02618.
  • 20.
    Amini M. [Frequency evaluation of the nosocomial infections and related factors in mostafa Khomeini hospital “ICU” based on “NNI” system]. Sci Res J Army Uni Med. 2009;7(1):9-14. FA.
  • 21.
    Hajibagheri K, Afrasiabian SH. [An epidemiologic study of nosocomial infections and its related factors at the intensive care unit of Tohid Hospital, in Sanandaj during 2003-2004]. Sci J Kurdistan Uni Med Sci. 2006;10(4):44-50. FA.
  • 22.
    Ghanshani R, Gupta R, Gupta BS, Kalra S, Khedar RS, Sood S. Epidemiological study of prevalence, determinants, and outcomes of infections in medical ICU at a tertiary care hospital in India. Lung India. 2015;32(5):441-8. [PubMed ID: 26628756]. [PubMed Central ID: PMC4586996]. https://doi.org/10.4103/0970-2113.164155.
  • 23.
    Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intens Care Med. 2002;28(2):108-21. [PubMed ID: 11907653]. https://doi.org/10.1007/s00134-001-1143-z.
  • 24.
    Mitharwal SM, Yaddanapudi S, Bhardwaj N, Gautam V, Biswal M, Yaddanapudi L. Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes. Am J Infect Control. 2016;44(7):e113-7. [PubMed ID: 26944004]. https://doi.org/10.1016/j.ajic.2016.01.021.
  • 25.
    Fereidooni Moghadam T, Azizian S, Wettig S. Synergistic behaviour of ZnO nanoparticles and gemini surfactants on the dynamic and equilibrium oil/water interfacial tension. Phys Chem Chem Phys. 2015;17(11):7122-9. [PubMed ID: 25687519]. https://doi.org/10.1039/c5cp00510h.
  • 26.
    Yaghubi T, Pourkazemi A, Farashbandi H, Ballu H. [Epidemiological study of nosocomial infections and antibiotic resistance patterns In Guilan]. sci mag yafte. 2019;21(1):52-62. FA.
  • 27.
    Bahrami M, Pouryousef A, Abbasian S, Eelbeigi Z, Faramarzi A. [Survey of the prevalence of nosocomial infections and Antibiotic Sensitivity and resistance in 9 Dey Hospital in Torbat heydareh between 2013-2016]. Beyhagh. 2018;23(4):21-10. FA.
  • 28.
    Hussainrezaee H, Borji E, Mirzadi I, Salehi A, Sivandipur H, Nekhei M, et al. [A study on the rate and the types of hospital infection in the trauma ICU departments of Kerman hospitals in the first half of 1393]. J Iran Soc Anaesthesiol Intens Care. 2015;37:91. FA.
  • 29.
    Askaryan M, Hosseini SR, Khayrandish P. [Role of incidence of blood and urinary tract infections in the burn patients admitted in Ghotbeddin burn center of shiraz, 2000-2001]. J Mazandaran Uni Med Sci. 2003;13(38):33-9. FA.
comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles